IceCure Medical Ltd (ICCM) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Caesarea, Israel. The current CEO is Eyal Shamir.
ICCM has IPO date of 2021-08-26, 64 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $24.37M.
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
